Ubiquitin stimulated reversal of topoisomerase 2 DNA-protein crosslinks by TDP2. Issue 11 (1st May 2020)

• Record Type: Journal Article
• Authors: Schellenberg, Matthew J; Appel, C Denise; Riccio, Amanda A; Butler, Logan R; Krahn, Juno M; Liebermann, Jenna A; Cortés-Ledesma, Felipe; Williams, R Scott
• Is Part Of: Nucleic acids research. Volume 48:Issue 11(2020)
• Page Start: 6310
• Page End: 6325
• Publication Date: 2020-05-01
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkaa318
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: Tyrosyl-DNA phosphodiesterase 2 (TDP2) reverses Topoisomerase 2 DNA–protein crosslinks (TOP2-DPCs) in a direct-reversal pathway licensed by ZATT ZNF451 SUMO2 E3 ligase and SUMOylation of TOP2. TDP2 also binds ubiquitin (Ub), but how Ub regulates TDP2 functions is unknown. Here, we show that TDP2 co-purifies with K63 and K27 poly-Ubiquitinated cellular proteins independently of, and separately from SUMOylated TOP2 complexes. Poly-ubiquitin chains of ≥ Ub3 stimulate TDP2 catalytic activity in nuclear extracts and enhance TDP2 binding of DNA–protein crosslinks in vitro . X-ray crystal structures and small-angle X-ray scattering analysis of TDP2-Ub complexes reveal that the TDP2 UBA domain binds K63-Ub3 in a 1:1 stoichiometric complex that relieves a UBA-regulated autoinhibitory state of TDP2. Our data indicates that that poly-Ub regulates TDP2-catalyzed TOP2-DPC removal, and TDP2 single nucleotide polymorphisms can disrupt the TDP2-Ubiquitin interface.